EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital

Gulhadiye Avcu, Ece Erci, Nimet Melis Bilen, Irem Ersayoglu, Gulcihan Ozek, Ulgen Celtik, Demet Terek, Feriha Cilli, Zumrut Sahbudak Bal

Journal of Antimicrobial Chemotherapy · 03.01.2025 · 80 (1) · 147-153

DOI: 10.1093/jac/dkae387 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 30.10.2024. Verfasst von Gulhadiye Avcu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatrics, Division of Pediatric Infectious Diseases, Ege University, Izmir, Turkey. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Enterobacteriaceae Infections, Anti-Bacterial Agents, Tertiary Care Centers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) infections among children represents a significant global concern, leading to elevated mortality rates. The aim of this study was to evaluate the risk factors, outcomes, 30-day mortality rates and contributing factors in children with CRE bloodstream infections (CRE-BSIs).

Methods

Data regarding demographic characteristics, treatment approaches and outcomes of hospitalized children aged 0–18 years diagnosed with CRE-BSIs between January 2018 and December 2022 were extracted from medical records. Mortality within 30 days of diagnosis and the predictive factors were analysed.

Results

A total of 114 children, with a median age of 11 months (range: 6–69.5), were included. All cases of CRE-BSIs were either healthcare associated or hospital acquired and presented with at least one underlying comorbidity. A previous history of CRE colonization or infection rate was 48.2% (55/114). Klebsiella pneumoniae 87.7% (100/114) was the most frequently isolated microorganism, with a 30-day mortality rate of 14% (16/114). Multivariate analysis identified paediatric intensive care unit admission, invasive mechanical ventilation, inotropic support and thrombocytopenia due to CRE-BSIs as the most discriminative predictors for 30-day mortality (P < 0.001). Central venous catheter (CVC) removal was associated with a reduced mortality rate (P = 0.012). High-dose prolonged infusion of MEM-based or polymyxin-based antibiotic combinations did not impact survival. Lower MEM MIC values were associated with improved survival.

Conclusions

The mortality rate of CRE-BSI is notably high in childhood. The use of antibiotic combination strategies did not demonstrate a significant impact on 30-day survival; however, the removal of CVCs was found to lower mortality rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsAnti-Bacterial AgentsTertiary Care CentersBacteremiaHospitals, UniversityHumansInfantMaleFemaleRetrospective StudiesChild, PreschoolChildAdolescentTreatment OutcomeRisk FactorsInfant, NewbornCarbapenems

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pediatrics, Division of Pediatric Infectious Diseases, Ege University, Izmir, Turkey.
  • Faculty of Medicine, Department of Pediatrics, Division of Pediatric Intensive Care, Ege University, Izmir, Turkey.
  • Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Ege University, Izmir, Turkey.
  • Faculty of Medicine, Department of Pediatric Surgery, Ege University, Izmir, Turkey.
  • Faculty of Medicine, Department of Neonatology, Ege University, Izmir, Turkey.
  • Faculty of Medicine, Department of Medical Microbiology, Ege University, Izmir, Turkey.

Zitieren

APA

Avcu, G., Erci, E., Bilen, N. M., Ersayoglu, I., Ozek, G., Celtik, U., Terek, D., Cilli, F., & Bal, Z. S. (2025). Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital. Journal of Antimicrobial Chemotherapy, 80(1), 147-153. https://doi.org/10.1093/jac/dkae387

Vancouver

Avcu G, Erci E, Bilen NM, Ersayoglu I, Ozek G, Celtik U, et al. Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital. Journal of Antimicrobial Chemotherapy. 2025;80(1):147-153. doi:10.1093/jac/dkae387

BibTeX
@article{Avcu2025,
  author = {Avcu, Gulhadiye and Erci, Ece and Bilen, Nimet Melis and Ersayoglu, Irem and Ozek, Gulcihan and Celtik, Ulgen and Terek, Demet and Cilli, Feriha and Bal, Zumrut Sahbudak},
  title = {Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {147--153},
  doi = {10.1093/jac/dkae387}
}
Kostenlos starten →